Bio Nucleus Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2015.
2015 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Bio Nucleus Pharmaceuticals Private Limited

Bio Nucleus Pharmaceuticals Private Limited, a active private limited company, was established on 19 January 2015 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U33110DL2015PTC275677. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Supriya Verma (Director), Kumar Prashant (Director). Past directors included Shyam Lal, Gaurav Karna, Rajiv Chhikara. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-2/144, Plot No-144, Upper G/Floor Gali No-3, Kh No-720/590, Mahavir Enclav, E, New Delhi, Delhi, 110045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110DL2015PTC275677

  • Registration Number

    275677

  • Incorporation Date

    19 January 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -22.73%
  • Profit Growth **** 146.96%
  • Ebitda **** 41.51%
  • Net Worth 1.30%
  • Total Assets -21.18%
Company report

Bio Nucleus Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bio Nucleus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bio Nucleus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Supriya Verma Director 30 Sep 2021 Current
Kumar Prashant Director 01 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Feb 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 08 Oct 2021 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 06 Nov 2015 Past
Pramod Abcsdd Director 20 Jun 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bio Nucleus Pharmaceuticals.

Bio Nucleus Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 22.73% decrease. The company also saw a substantial improvement in profitability, with a 146.96% increase in profit. The company's net worth moved up by a moderate rise of 1.3%.

Bio Nucleus Pharmaceuticals revenue growth over time
Bio Nucleus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -22.73%
*******
*******
*******
*******
Revenue from Operations
*******
 -23.68%
*******
*******
*******
*******
Total Assets
*******
 -21.18%
*******
*******
*******
*******
Profit or Loss
*******
 146.96%
*******
*******
*******
*******
Net Worth
*******
 1.30%
*******
*******
*******
*******
EBITDA
*******
 41.51%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bio Nucleus Pharmaceuticals?

In 2018, Bio Nucleus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bio Nucleus Pharmaceuticals?

Unlock and access historical data on people associated with Bio Nucleus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bio Nucleus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Nucleus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bio Nucleus Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Bio Nucleus Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Bio Nucleus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Supriya Verma was appointed as a Director was appointed as a Director on 30 Sep 2021 & has been associated with this company since 4 years 5 months . was documented.

  • Director Appointment

    Progress on Kumar Prashant was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 8 years 28 days . was documented.

  • Company Incorporation

    Bio Nucleus Pharmaceuticals Private Limited was registered on 19 Jan 2015 with Roc Delhi & aged 11 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bio Nucleus Pharmaceuticals Private Limited?

The CIN of Bio Nucleus Pharmaceuticals Private Limited is U33110DL2015PTC275677.

Where is Bio Nucleus Pharmaceuticals Private Limited headquartered?

Bio Nucleus Pharmaceuticals Private Limited is headquartered at D-2/144, Plot No-144, Upper G/Floor Gali No-3, Kh No-720/590, Mahavir Enclav, E, New Delhi, Delhi, 110045.

When was Bio Nucleus Pharmaceuticals Private Limited incorporated?

Bio Nucleus Pharmaceuticals Private Limited was incorporated on 19 January 2015.

Who are the current directors of Bio Nucleus Pharmaceuticals Private Limited?

The current directors of Bio Nucleus Pharmaceuticals Private Limited are

What is the primary industry of Bio Nucleus Pharmaceuticals Private Limited?

The primary industry of Bio Nucleus Pharmaceuticals Private Limited is Pharma.

Is Bio Nucleus Pharmaceuticals Private Limited a listed company?

Bio Nucleus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bio Nucleus Pharmaceuticals Private Limited?

The authorized capital of Bio Nucleus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Bio Nucleus Pharmaceuticals Private Limited?

The compliance status of Bio Nucleus Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available